BACK TO TOP
KSE100
170,765.22
266.28
(0.16%)
KSE100PR
51,483.72
80.28
(0.16%)
ALLSHR
103,241.05
137.96
(0.13%)
KSE30
50,813.89
74.20
(0.15%)
KMI30
244,391.30
186.14
(0.08%)
BKTI
47,274.31
141.41
(0.30%)
OGTI
35,009.43
46.87
(0.13%)
KMIALLSHR
66,928.26
55.24
(0.08%)
PSXDIV20
77,992.00
238.08
(0.31%)
UPP9
60,824.99
27.95
(0.05%)
NITPGI
45,312.56
34.95
(0.08%)
NBPPGI
48,711.08
51.31
(0.11%)
MZNPI
30,508.45
7.49
(0.02%)
JSMFI
43,460.24
118.32
(0.27%)
ACI
22,103.89
89.38
(0.41%)
JSGBKTI
71,590.63
242.68
(0.34%)
HBLTTI
19,106.07
24-09-2026
3.61
(0.02%)
MII30
22,080.00
14.26
(0.06%)
Macter International Limited
PHARMACEUTICALS
Rs.258.92
3.59
(1.41%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Fri, Sep 25, 2026 4:49 PM
REG
DFC
CSF
ODL
Open
249.00
High
271.99
Low
249.00
Volume
23,936
CIRCUIT BREAKER
229.80 — 280.86
DAY RANGE
249.00 — 271.99
52-WEEK RANGE ^
235.34 — 395.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
255.33
VAR
15.50
HAIRCUT
22.50
P/E Ratio (TTM) **
16.99
1-Year Change * ^
-34.00%
YTD Change * ^
-22.00%

No record found

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Macter International Limited was incorporated in Pakistan in 1992 as a private limited company and was converted into a public limited company in 2011. The principal activity of the company is to manufacture and market pharmaceutical products.

KEY PEOPLE
Asif MisbahCEO
Amanullah KassimChairperson
Asif JavedCompany Secretary
ADDRESS

F-216, SITE, Karachi

WEBSITE

www.macter.com

REGISTRAR

F.D. Registrar Services (SMC-Pvt) Ltd 17th Floor, Saima Trade Tower-A I.I. Chundrigar Road, Karachi

AUDITOR

AF Ferguson Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
11,861,388.78
Shares
45,811,018
Free Float
18,324,407
Free Float
40.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Sep 23, 2026Financial Results for the Year Ended June 30, 2026 View   PDF
Apr 30, 2026Transmission of Quarterly Report for the Period Ended March 31, 2026 View   PDF
Apr 27, 2026Financial Results for the Quarter Ended March 31, 2026 View   PDF
Feb 25, 2026Transmission of Quarterly Report for the Period Ended 31-12-2025 View   PDF
Feb 16, 2026Financial Results for the Half Year ended December 31, 2025 View   PDF
DateTitleDocument
Sep 22, 2026Board Meeting In Progress View   
Sep 15, 2026Board Meeting View   
Jun 12, 2026Board Meeting Other Than Financial Results View   PDF
Apr 17, 2026Board Meeting View   
Feb 6, 2026Board Meeting View   
DateTitleDocument
Sep 25, 2026Material Information View   PDF
Sep 23, 2026Material Information View   PDF
Sep 7, 2026Change of Chief Financial Officer View   
Aug 7, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Aug 6, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2026202520242023
Sales11,731,8569,914,3187,535,3826,680,391
Profit after Taxation698,254737,534427,163392,868
EPS15.2416.109.328.58
Q3 2026Q2 2026Q1 2026Q3 2025
Sales2,786,5123,340,9342,768,9852,426,952
Profit after Taxation91,751270,940156,22094,913
EPS2.005.913.412.07
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2026202520242023
Gross Profit Margin (%)48.2544.9642.2241.68
Net Profit Margin (%)5.957.445.675.88
EPS Growth (%)(5.34)72.758.6219.33
PEG(3.37)0.431.170.59

Payouts

Financial Reports